ArticleContemporary clinical trials2020

Comparison of Phase I-II designs with parametric or semi-parametric models using two different risk-benefit trade-off criteria.

Andrew G Chapple et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.